Literature DB >> 22227127

Intermedin elicits a negative inotropic effect in rat papillary muscles mediated by endothelial-derived nitric oxide.

Ana Luísa Pires1, Marta Pinho, Cristina Maria Sena, Raquel Seica, Adelino F Leite-Moreira.   

Abstract

Intermedin (IMD) is a novel vasoactive peptide from the calcitonin gene-related peptide (CGRP) implicated in cardiac regulation, yet the contractile effects of IMD remain controversial, since previous studies in vivo and isolated cardiomyocytes documented contradictory results. We hypothesized cardiac endothelial cells involvement in IMD modulation of cardiac function as an explanation for these opposing observations. With this in mind, we investigated the direct action of increasing concentrations of IMD (10(-8) to 10(-6)M) on myocardial performance parameters in rat left ventricular (LV) papillary muscles with and without endocardial endothelium (EE) and in presence of receptor antagonists and intracellular pathways inhibitors. In LV papillary muscles with intact EE, IMD induced a concentration-dependent negative inotropic action (%decrease relative to baseline, at IMD concentration of 10(-6)M, active tension of 14 ± 4%, and maximum velocity of tension rise of 10 ± 4%). These effects were blunted by EE removal, AM receptor antagonist (AM(22-52)), and CGRP receptor antagonist (CGRP(8-37)). Additionally, nitric oxide (NO) synthase inhibition with N(G)-nitro-l-arginine (l-NAME) in muscles with and without EE and guanylyl cyclase inhibition with {1H-[1,2,4]oxadiazole-[4,4-a]-quinoxalin-1-one} not only blunted the negative inotropic action of IMD but also unmasked IMD-positive inotropic effect dependent on CGRP receptor PKA activation. Western blot quantification of phosphorylated cardiac troponin I (P-cTnI) in IMD-treated papillary muscles revealed a significant increase in P-cTnI when compared with untreated muscles, while in l-NAME-pretreated papillary muscles IMD failed to increase P-cTnI. Finally, we found that stimulation of both EE and microvascular endothelial cells with IMD significantly increased NO production by 40 ± 3 and 38 ± 3%, respectively, suggesting the role of cardiac endothelial cells in NO production upon IMD stimulation. Our findings establish IMD negative inotropic effect in isolated myocardium due to NO/cGMP pathway activation with concomitant thin myofilament desensitization by increase in cTnI phosphorylation and provide a coherent explanation for the previously reported contradictory results.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22227127     DOI: 10.1152/ajpheart.00877.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  5 in total

Review 1.  Adrenomedullin 2/intermedin: a putative drug candidate for treatment of cardiometabolic diseases.

Authors:  Song-Yang Zhang; Ming-Jiang Xu; Xian Wang
Journal:  Br J Pharmacol       Date:  2017-05-16       Impact factor: 8.739

2.  Reverse myocardial effects of intermedin in pressure-overloaded hearts: role of endothelial nitric oxide synthase activity.

Authors:  Ana Luísa Pires; Marta Pinho; Bárbara Silvana Alves; Sónia Pinho; Cristina Sena; Raquel Maria Seica; Adelino F Leite-Moreira
Journal:  J Physiol       Date:  2012-11-19       Impact factor: 5.182

3.  Calcitonin Gene-Related Peptide Regulates Cardiomyocyte Survival through Regulation of Oxidative Stress by PI3K/Akt and MAPK Signaling Pathways.

Authors:  Nsini A Umoh; Robin K Walker; Richard M Millis; Mustafa Al-Rubaiee; Pandu R Gangula; Georges E Haddad
Journal:  Ann Clin Exp Hypertens       Date:  2014-01

4.  Inotropic and lusitropic effects of calcitonin gene-related peptide in the heart.

Authors:  Mustafa Al-Rubaiee; Pandu R Gangula; Richard M Millis; Robin K Walker; Nsini A Umoh; Valerie M Cousins; Miara A Jeffress; Georges E Haddad
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

5.  Intermedin in rat uterus: changes in gene expression and peptide levels across the estrous cycle and its effects on uterine contraction.

Authors:  Chi-Wai Wong; Wai-Sum O; Fai Tang
Journal:  Reprod Biol Endocrinol       Date:  2013-02-25       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.